Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Open-Label, Active-Controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa

NCT01315678 is registered in ClinicalTrials.gov with Insmed Incorporated as lead sponsor.

NCT NCT01315678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01315678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Open-Label, Active-Controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa
Lead sponsor
Insmed Incorporated
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2012
Completion date
September 18, 2013
Enrollment
302 (actual)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

pseudomonas aeruginosa infection